Maarit Anttila - Publications, H-index & Citations

Maarit Anttila

Department of Gynecology

34H指数

135论文数

3.4K被引数

收录论文 25

发表时间

Exploring survival-associated transcriptomic subtypes in ovarian cancer using RNAseq from FFPE tissues in a clinical trial cohort 探索卵巢癌中与生存相关的转录组亚型：使用来自临床 trial 研究队列的石蜡包埋组织 RNAseq 数据

Translational Oncology

IF4.1

2026-03-19

OAAI

Maj K Kjeldsen; Frederik Otzen Bagger; Henrik Roed; Gitte-Bettina Nyvang; Charlotte Aaquist Haslund; Anja Oer Knudsen; Anne Krejbjerg Motavaf; Susanne Malander; Maarit Anttila; Gabriel Lindahl; Johanna Mäenpää; Maria Dimoula; Theresa Werner; Trine Zeeberg Iversen; Sakari Hietanen; Lars Fokdal; Hanna Dahlstrand; Line Bjørge; Michael Birrer; Mansoor Raza Mirza

Proteogenomic approach to immunopeptidomics of ovarian tumors identifies shared peptide vaccine candidates 蛋白质组学方法应用于卵巢肿瘤免疫肽组学，识别出共享肽疫苗候选物

npj Vaccines

IF6.5

2025-08-16

OAAI

Jacopo Chiaro; Karita Peltonen; Kadri Õunap; Aubrey Bailey; Sara Feola; Sara Wojciechowski; Masoumeh Es-Haghi; Mikel Azkargorta; Félix Elortza; Salvatore Russo; Hanna Sallinen; Maarit Anttila; Olga Gurvich; Vincenzo Cerullo; Tuija Kekarainen

Dynamic contrast-enhanced MRI to characterize angiogenesis in primary epithelial ovarian cancer: An exploratory study

EUROPEAN JOURNAL OF RADIOLOGY

IF3.3

2023-08-01

OAAI

Lindgren, Auni; Anttila, Maarit; Arponen, Otso; Hamalainen, Kirsi; Kononen, Mervi; Vanninen, Ritva; Sallinen, Hanna

Neoadjuvant chemotherapy induces an elevation of tumour apparent diffusion coefficient values in patients with ovarian cancer

BMC CANCER

IF3.4

2023-04-01

OAAI

Reijonen, Milja; Holopainen, Erikka; Arponen, Otso; Kononen, Mervi; Vanninen, Ritva; Anttila, Maarit; Sallinen, Hanna; Rinta-Kiikka, Irina; Lindgren, Auni

AAV8-mediated sVEGFR2 and sVEGFR3 gene therapy combined with chemotherapy reduces the growth and microvasculature of human ovarian cancer and prolongs the survival in mice

FRONTIERS IN MEDICINE

IF3

2022-12-08

OAAI

Kujala, Anni; Valkonen, Elina; Sallinen, Hanna; Tuppurainen, Laura; Laakso, Hanne; Yla-Herttuala, Elias; Liimatainen, Timo; Kujala, Jouni; Jokelainen, Otto; Sironen, Reijo; Anttila, Maarit; Yla-Herttuala, Seppo

Comparative transcriptome analysis of matched primary and distant metastatic ovarian carcinoma

BMC CANCER

IF3.4

2019-11-19

OAAI

Sallinen, H.; Janhonen, S.; Polonen, P.; Niskanen, H.; Liu, O. H.; Kivela, A.; Hartikainen, J. M.; Anttila, M.; Heinaeniemi, M.; Yla-Herttuala, S.; Kaikkonen, M. U.

Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer Vegf-a，vegf-d和VEGFR1在远处转移中的表达谱高于匹配的原发性高级别上皮性卵巢癌

BMC CANCER

IF3.4

2019-06-14

OAAI

Sopo, Minna; Anttila, Maarit; Hamalainen, Kirsi; Kivela, Annukka; Yla-Herttuala, Seppo; Kosma, Veli-Matti; Keski-Nisula, Leea; Sallinen, Hanna

Prognostic value of preoperative dynamic contrast-enhanced magnetic resonance imaging in epithelial ovarian cancer

EUROPEAN JOURNAL OF RADIOLOGY

IF3.3

2019-06-01

PREAI

Lindgren, Auni; Anttila, Maarit; Arponen, Otso; Rautiainen, Suvi; Kononen, Mervi; Vanninen, Ritva; Sallinen, Hanna

Cervical cancer staging, pretreatment planning, and surgical treatment in the Nordic countriesSurvey from the Surgical Subcommittee of the Nordic Society of Gynecological Oncology 北欧国家的宫颈癌分期，预处理计划和手术治疗来自北欧妇科肿瘤学会外科小组委员会的报告

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

IF3.1

2018-06-26

OAAI

Fuglsang, Katrine; Haldorsen, Ingfrid S.; Avall-Lundqvist, Elisabeth; Lindahl, Gabriel; Roed, Henrik; Woie, Kathrine; Pakarinen, Paivi; Thoroddsen, Asgeir; Anttila, Maarit; Blaakaer, Jan

Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer

BMC CANCER

IF3.4

2014-09-23

OAAI

Sallinen, Hanna; Heikura, Tommi; Koponen, Jonna; Kosma, Veli-Matti; Heinonen, Seppo; Yia-Herttuala, Seppo; Anttila, Maarit

Antiangiogenic gene therapy with soluble VEGF-receptors-1,-2 and-3 together with paclitaxel prolongs survival of mice with human ovarian carcinoma

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2012-03-27

OAAI

Sopo, Minna; Anttila, Maarit; Sallinen, Hanna; Tuppurainen, Laura; Laurema, Anniina; Laidinen, Svetlana; Hamalainen, Kirsi; Tuunanen, Pasi; Koponen, Jonna K.; Kosma, Veli-Matti; Heinonen, Seppo; Alitalo, Kari; Yla-Herttuala, Seppo

Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility

BREAST CANCER RESEARCH AND TREATMENT

IF3

2011-07-13

PREAI

Vuorela, Mikko; Pylkas, Katri; Hartikainen, Jaana M.; Sundfeldt, Karin; Lindblom, Annika; Wappling, Anna von Wachenfeldt; Haanpaa, Maria; Puistola, Ulla; Rosengren, Annika; Anttila, Maarit; Kosma, Veli-Matti; Mannermaa, Arto; Winqvist, Robert

Downregulated CD44 and hyaluronan expression in vulvar intraepithelial neoplasia and squamous cell carcinomas CD44和透明质酸在外阴上皮内瘤变和鳞状细胞癌中的表达下调

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

IF3.1

2010-12-31

OAAI

Hamalainen, Kirsi; Kosma, Veli-Matti; Eloranta, Marja-Liisa; Tammi, Raija; Tammi, Markku; Leppanen, Marjo; Leppanen, Merja; Heinonen, Seppo; Anttila, Maarit

Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma

BMC CANCER

IF3.4

2010-09-27

OAAI

Nykopp, Timo K.; Rilla, Kirsi; Tammi, Markku I.; Tammi, Raija H.; Sironen, Reijo; Hamalainen, Kirsi; Kosma, Veli-Matti; Heinonen, Seppo; Anttila, Maarit

Cotargeting of VEGFR-1 and-3 and angiopoietin receptor Tie2 reduces the growth of solid human ovarian cancer in mice

CANCER GENE THERAPY

IF5

2010-09-24

OAAI

Sallinen, H.; Anttila, M.; Grohn, O.; Koponen, J.; Hamalainen, K.; Kholova, I.; Kosma, V-M; Heinonen, S.; Alitalo, K.; Yla-Herttuala, S.

Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression

BMC CANCER

IF3.4

2009-08-20

OAAI

Tuhkanen, Hanna; Soini, Ylermi; Kosma, Veli-Matti; Anttila, Maarit; Sironen, Reijo; Hamalainen, Kirsi; Kukkonen, Laura; Virtanen, Ismo; Mannermaa, Arto

Expression of Hyaluronan Synthases (HAS1-3) and Hyaluronidases (HYAL1-2) in Serous Ovarian Carcinomas: Inverse Correlation between HYAL1 and Hyaluronan Content

BMC CANCER

IF3.4

2009-05-12

OAAI

Nykopp, Timo K.; Rilla, Kirsi; Sironen, Reijo; Tammi, Markku I.; Tammi, Raija H.; Hamalainen, Kirsi; Heikkinen, Anna-Mari; Komulainen, Marja; Kosma, Veli-Matti; Anttila, Maarit

Antiangiogenic Gene Therapy With Soluble VEGFR-1,-2, and-3 Reduces the Growth of Solid Human Ovarian Carcinoma in Mice

MOLECULAR THERAPY

IF12

2009-02-01

OAAI

Sallinen, Hanna; Anttila, Maarit; Narvainen, Johanna; Koponen, Jonna; Hamalainen, Kirsi; Kholova, Ivana; Heikura, Tommi; Toivanen, Pyry; Kosma, Veli-Matti; Heinonen, Seppo; Alitalo, Kari; Yla-Herttuala, Seppo

Quantification of angiogenesis by the Chalkley method and its prognostic significance in epithelial ovarian cancer 通过Chalkley方法定量血管生成及其在上皮性卵巢癌中的预后意义

EUROPEAN JOURNAL OF CANCER

IF7.1

2007-05-01

PREAI

Suhonen, Kirsi A.; Anttila, Maarit A.; Sillanpaa, Sari M.; Hamalainen, Kirsi M.; Saarikoski, Seppo V.; Juhola, Matti; Kosma, Veli-Matti

Prognostic significance of matrix metalloproteinase-7 in epithelial ovarian cancer and its relation to β-catenin expression

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2006-06-27

OAAI

Sillanpaa, Sari M.; Anttila, Maarit A.; Voutilainen, Kirsi A.; Ropponen, Kirsi M.; Sironen, Reijo K.; Saarikoski, Seppo V.; Kosma, Veli-Matti

研究方向